Translational Development... (TDAC)
NASDAQ: TDAC
· Real-Time Price · USD
10.32
0.00 (0.00%)
At close: Aug 15, 2025, 10:41 AM
Company Description
Translational Development Acquisition Corp. does not have significant operations.
It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Translational Development Acquisition Corp.
| Country | United States |
| IPO Date | Feb 20, 2025 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | 2 |
| CEO | Michael M. B. Hoffman |
Contact Details
Address: 77 Water St Fl 8 New York City, New York United States | |
| Website | https://www.translational-development.com |
Stock Details
| Ticker Symbol | TDAC |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001673481 |
| CUSIP Number | G9008W105 |
| ISIN Number | KYG9008W1050 |
| Employer ID | 81-1996183 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Michael M. B. Hoffman J.D. | Chairman of the Board & Chief Executive Officer |
| Avi C. Das | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2025 | 8-K | Current Report |
| Aug 14, 2025 | 10-Q | Quarterly Report |
| Aug 07, 2025 | 8-K | Current Report |
| Jul 31, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Jul 22, 2025 | 8-K | Current Report |
| Jul 16, 2025 | 8-K | Current Report |
| Jul 11, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Jul 07, 2025 | 8-K | Current Report |
| Jul 03, 2025 | 8-K | Current Report |
| Jul 03, 2025 | S-8 POS | Filing |